期刊文献+

洛沙坦对血管紧张素Ⅱ诱导的心肌细胞c-fos表达及对细胞内游离钙升高的拮抗作用 被引量:1

Inhibitory effects of Losartan on c-fos expression and intracellular free calcium elevation induced by Angiotensio Ⅱin cardiomyocytes of neonatal rats
下载PDF
导出
摘要 目的研究血管紧张素AT1 亚型受体拮抗剂洛沙坦(losartan,LT)对血管紧张素Ⅱ(AngⅡ)诱导的心肌细胞c_fos表达及细胞内游离钙变化的影响。方法斑点杂交及Fura_2技术。结果AngⅡ10nmol/L能诱导培养乳鼠心肌细胞c_fos的一过性高表达及[Ca2 + ]的显著升高。LT20μmol/L能显著抑制Ang Ⅱ诱导的心肌细胞c_fos的高表达 ,而血管紧张素AT2 亚型受体拮抗剂PD123319则无明显作用。LT1~100μmol/L能剂量依赖性地抑制AngⅡ引起的[Ca2 + ]i升高。结论Ang Ⅱ诱导的心肌细胞c_fos高表达及[Ca2 + ]i升高可能是通过AT1 亚型受体介导而实现的 。 Aim To study effects of Losartan on c_fos mRNA expression and free intracellular Ca2+(i) level induced by Angiotension Ⅱ(AngⅡ) in cardiomyocytes of neonatal rats . Methods Effect of Losartan on c_fos mRNA expression induced by Ang Ⅱ in cardiomyocytes was studied with dot blotting assay. Ca2+ was measured with Ca2+sensitive fluorescent indicator (Fura_2/AM) using AR_CM_MIE cation measurement system. Results AngⅡ temporally induced c_fos gene expression and significantly increased the i elevation in cardiomyocytes of neonatal rats . However, the dynamic changes of c_fos gene expression and i could be inhibited by Losartan 20 μmol/L, but not by PD123319. Losartan 1?100 μmol/L significantly inhibited Ang Ⅱ induced i elevation in a dose_dependent manner. Conclusion The results suggest that c_fos expression and i elevation induced by AngⅡ are mediated by AT1 subtype acceptor. Losartan may be an effective drug in treating cardiac hypertrophy.
出处 《中国临床药理学与治疗学杂志》 CSCD 1998年第4期261-264,共4页
关键词 细胞内游离钙 洛沙坦 血管紧张素Ⅱ C-FOS原癌基因 FURA-2 心肌细胞 斑点杂交技术 losartan angiotension Ⅱ c_fos proto_oncogene, Fura_2 cardiomyocytes
  • 相关文献

参考文献2

二级参考文献1

  • 1David W. Speicher,Jon N. Peace,Richard L. McCarl. Effects of plating density and age in culture on growth and cell division of neonatal rat heart primary cultures[J] 1981,In Vitro(10):863~870

共引文献8

同被引文献5

  • 1Januzzi JL,Chenj-Tournoux AA,Moe G.Amino-terminalpro-B-type natriuretic peptide testing for the diagnosis orexclusion of heart failure in patients with acute symptoms[J].Am J C ardiol,2008,101(3A):29-38.
  • 2Pfister R,Schneier CA.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:ap-plication of natriuretic peptides[J],Eur Heart J,2009,30(3):382-383.
  • 3Martinez-Rumayor AA,Vazquez J,Rehman SU,et al.Rel-ative value ofamino-terminal pro-B-typenatriuretic peptide testing and radiographic standards for the diagnositic evaluation of heart failure in acutely dysp-neic subjects[J].Biomarkers,2012,15(2):175-182.
  • 4Robaei D,Koe L,Bais R,et al.Effect of NT-proBNP testing on diagnostic certainty in patients admitted to the emergency department with possible heart failure[J].Annclin Biochem,2011,48(Pt 3):212-217.
  • 5无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3675

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部